See more : Yifeng Pharmacy Chain Co., Ltd. (603939.SS) Income Statement Analysis – Financial Results
Complete financial analysis of NorthView Acquisition Corporation (NVAC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NorthView Acquisition Corporation, a leading company in the Shell Companies industry within the Financial Services sector.
- Legend Mining Limited (LEG.AX) Income Statement Analysis – Financial Results
- Primo Brands Corporation (PRMB) Income Statement Analysis – Financial Results
- S&P Global Inc. (SPGI) Income Statement Analysis – Financial Results
- JPMorgan Emerging Europe Middle East & Africa Securities Plc (JEMA.L) Income Statement Analysis – Financial Results
- Pinelawn Cemetery (PLWN) Income Statement Analysis – Financial Results
NorthView Acquisition Corporation (NVAC)
About NorthView Acquisition Corporation
NorthView Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare sector. The company was incorporated in 2021 and is based in New York, New York. NorthView Acquisition Corporation is a subsidiary of NorthView Sponsor I, LLC.
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.51M | 1.27M | 0.00 |
| Gross Profit | -1.51M | -1.27M | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 1.27M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 |
| SG&A | 1.51M | 1.27M | 45.05K |
| Other Expenses | 0.00 | 0.00 | -45.05K |
| Operating Expenses | 0.00 | 1.27M | 45.05K |
| Cost & Expenses | 1.51M | 1.27M | 45.05K |
| Interest Income | 2.25M | 2.58M | 9.69K |
| Interest Expense | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.51M | 1.27M | 67.57K |
| EBITDA | 3.13M | 7.67M | 300.43K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.51M | -1.27M | -45.05K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 3.13M | 8.94M | 345.48K |
| Income Before Tax | 1.62M | 7.67M | 300.43K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 456.79K | 499.21K | -345.48K |
| Net Income | 1.16M | 7.17M | 300.43K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% |
| EPS | 0.19 | 0.30 | 0.01 |
| EPS Diluted | 0.19 | 0.30 | 0.01 |
| Weighted Avg Shares Out | 6.10M | 24.17M | 24.17M |
| Weighted Avg Shares Out (Dil) | 6.10M | 24.17M | 24.17M |
NorthView Acquisition Corporation Announces Exception Granted by Nasdaq to Permit to The Company to Regain Compliance with Listing Rules
NorthView Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Filing of Annual Report on Form 10-Q
Source: https://incomestatements.info
Category: Stock Reports